A Study of LP-128 Capsules in Healthy Subjects

Clinical trial NCT05130567 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05130567
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis b

Start date: 2021-11-19
Primary completion: 2026-09-30
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.